Pharmacist-managed vaccination program increased influenza vaccination rates in cardiovascular patients enrolled in a secondary prevention lipid clinic

Pharmacotherapy

Volumn 27, Issue 5, 2007, Pages 729-733

  Loughlin, Susan M ^a,b   Mortazavi, Ali ^b   Garey, Kevin W ^a   Rice, Gary K ^b   Birtcher, Kim K ^a,b  

^a UNIVERSITY OF HOUSTON   (United States)

^b Kelsey Seybold Clinic   (United States)

Author keywords

Gender; Influenza vaccine; Lipids; Prevention; Risk factors

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ANALYTIC METHOD; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PHARMACIST; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; RETROSPECTIVE STUDY; REVIEW; STATISTICAL ANALYSIS;

AGE FACTORS; AMBULATORY CARE FACILITIES; CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA VACCINES; MALE; PHARMACEUTICAL SERVICES; PHARMACISTS; PROFESSIONAL ROLE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; VACCINATION;

EID: 34247862152     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.27.5.729     Document Type: Review

References (15)

1. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 2006;55:1-40.
2. Nichol KL. Influenza vaccination in the elderly: impact on hospitalization and mortality. Drugs Aging 2005;22:495-515.
3. Davis MM, Taubert K, Benin AL, et al. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation 2006;114:1549-53.
4. Calis KA, Hutchison LC, Elliott ME, et al. Healthy people 2010: challenges, opportunities, and a call to action for America's pharmacists. Pharmacotherapy 2004;24:1241-94.
5. Kamal KM, Madhavan SS, Maine LL. Pharmacy and immunization services: pharmacists' participation and impact. J Am Pharm Assoc 2003;43:470-82.
6. Steyer TE, Ragucci KR, Pearson WS, Mainous AG. The role of pharmacists in the delivery of influenza vaccinations. Vaccine 2004;22:1001-6.
7. Bourdet SV, Kelley M, Rublein J, Williams DM. Effect of a pharmacist-managed program of pneumococcal and influenza immunization on vaccination rates among adult inpatients. Am J Health-Syst Pharm 2003;60:1767-71.
8. Van Amburgh JA, Waite NM, Hobson EH, Migden H. Improved influenza vaccination rates in a rural population as a result of a pharmacist-managed immunization campaign. Pharmacotherapy 2001;21:1115-22.
9. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003;348:1322-32.
10. Hak E, Buskens E, van Essen GA, et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med 2005;165:274-80.
11. Lavallee P, Perchaud V, Gautier-Bertrand M, Grabli D, Amarenco P. Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002;33:513-18.
12. Naghavi M, Barlas Z, Saidaty S, Naquib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000;102:3039-45.
13. Singleton JA, Poel AJ, Lu P, Nichol KL, Iwane MK. Where adults reported receiving influenza vaccination in the United States. Am J Infect Control 2005;33:563-70.
14. Singleton JA, Wortley P, Lu PJ. Influenza vaccination of persons with cardiovascular disease in the United States. Tex Heart Inst J 2004;31:22-7.
15. Davis MM, McMahon SR, Santoli JM, Schwartz B, Clark SJ. A national survey of physician practices regarding influenza vaccine. J Gen Intern Med 2002;17:670-6.